PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 1 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $99,732 | -37.3% | 11,944 | -0.1% | 0.00% | -50.0% |
| Q2 2023 | $159,015 | -21.9% | 11,956 | -32.0% | 0.00% | -20.0% |
| Q1 2023 | $203,669 | +23.7% | 17,588 | -12.6% | 0.01% | 0.0% |
| Q4 2022 | $164,663 | +138.6% | 20,130 | +68.9% | 0.01% | +150.0% |
| Q3 2022 | $69,000 | +53.3% | 11,916 | +17.1% | 0.00% | 0.0% |
| Q2 2022 | $45,000 | -78.7% | 10,179 | +23.1% | 0.00% | -71.4% |
| Q3 2021 | $211,000 | -25.7% | 8,270 | +1.7% | 0.01% | -30.0% |
| Q2 2021 | $284,000 | -1.0% | 8,134 | -5.6% | 0.01% | -9.1% |
| Q1 2021 | $287,000 | +27.6% | 8,613 | -0.6% | 0.01% | +22.2% |
| Q4 2020 | $225,000 | +508.1% | 8,669 | -28.2% | 0.01% | +350.0% |
| Q1 2020 | $37,000 | -44.8% | 12,078 | -7.4% | 0.00% | -33.3% |
| Q4 2019 | $67,000 | – | 13,045 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madrone Advisors, LLC | 16,415,933 | $218,331,909 | 38.11% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,015,495 | $26,806,084 | 19.75% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $19,469,498 | 6.11% |
| Iron Triangle Partners LP | 2,400,000 | $31,920,000 | 4.27% |
| Jackson Square Partners, LLC | 8,517,624 | $113,284,399 | 3.30% |
| BOURNE LENT ASSET MANAGEMENT INC | 580,000 | $7,714,000 | 2.69% |
| ARK Investment Management | 26,634,620 | $354,240,443 | 2.34% |
| ARDSLEY ADVISORY PARTNERS LP | 906,000 | $12,049,800 | 2.04% |
| Avidity Partners Management LP | 4,337,400 | $57,687,420 | 2.02% |
| Nikko Asset Management Americas, Inc. | 13,649,948 | $181,271,309 | 1.91% |